Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Meniere Disease | 4 | 2026 | 15 | 2.760 |
Why?
|
| Cochlear Implantation | 7 | 2023 | 15 | 2.030 |
Why?
|
| Cochlear Implants | 7 | 2023 | 22 | 1.930 |
Why?
|
| Deafness | 3 | 2025 | 39 | 1.600 |
Why?
|
| Migraine Disorders | 2 | 2025 | 45 | 1.560 |
Why?
|
| Dizziness | 3 | 2021 | 18 | 1.520 |
Why?
|
| Telemedicine | 3 | 2025 | 360 | 1.210 |
Why?
|
| Hearing Loss, Sensorineural | 4 | 2023 | 39 | 1.180 |
Why?
|
| Cognitive Dysfunction | 2 | 2022 | 351 | 1.100 |
Why?
|
| Tinnitus | 3 | 2025 | 16 | 1.000 |
Why?
|
| Otologic Surgical Procedures | 3 | 2021 | 8 | 1.000 |
Why?
|
| Music | 4 | 2023 | 75 | 1.000 |
Why?
|
| Mastoidectomy | 3 | 2021 | 4 | 0.990 |
Why?
|
| Otolaryngology | 3 | 2021 | 18 | 0.970 |
Why?
|
| Sensory Thresholds | 1 | 2025 | 5 | 0.940 |
Why?
|
| Motion Perception | 1 | 2025 | 7 | 0.940 |
Why?
|
| Vestibular Evoked Myogenic Potentials | 2 | 2025 | 3 | 0.920 |
Why?
|
| Nystagmus, Optokinetic | 1 | 2025 | 1 | 0.900 |
Why?
|
| Speech Perception | 3 | 2023 | 77 | 0.890 |
Why?
|
| Hearing Loss, Sudden | 2 | 2022 | 3 | 0.860 |
Why?
|
| Aerosols | 3 | 2021 | 46 | 0.850 |
Why?
|
| Smartphone | 1 | 2025 | 72 | 0.830 |
Why?
|
| Pitch Perception | 3 | 2023 | 24 | 0.790 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 207 | 0.780 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 221 | 0.780 |
Why?
|
| Bilateral Vestibulopathy | 1 | 2022 | 1 | 0.770 |
Why?
|
| Personal Protective Equipment | 4 | 2021 | 27 | 0.760 |
Why?
|
| Vestibular Diseases | 1 | 2022 | 8 | 0.750 |
Why?
|
| Spatial Navigation | 1 | 2022 | 7 | 0.750 |
Why?
|
| Physical Examination | 2 | 2021 | 110 | 0.730 |
Why?
|
| Vertigo | 1 | 2021 | 18 | 0.700 |
Why?
|
| Biological Products | 1 | 2022 | 101 | 0.670 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 493 | 0.660 |
Why?
|
| Ear Diseases | 1 | 2020 | 5 | 0.660 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 22 | 0.640 |
Why?
|
| Betacoronavirus | 3 | 2020 | 182 | 0.630 |
Why?
|
| Tympanic Membrane Perforation | 1 | 2019 | 3 | 0.600 |
Why?
|
| Algorithms | 2 | 2025 | 1048 | 0.590 |
Why?
|
| Prospective Studies | 6 | 2026 | 3340 | 0.570 |
Why?
|
| Auditory Perception | 5 | 2025 | 36 | 0.570 |
Why?
|
| Humans | 34 | 2026 | 65446 | 0.540 |
Why?
|
| Wound Healing | 1 | 2019 | 196 | 0.530 |
Why?
|
| Adult | 13 | 2026 | 17387 | 0.490 |
Why?
|
| Cross-Sectional Studies | 6 | 2026 | 2696 | 0.480 |
Why?
|
| Pandemics | 6 | 2021 | 674 | 0.440 |
Why?
|
| Audiometry, Pure-Tone | 3 | 2026 | 29 | 0.430 |
Why?
|
| Vestibular Function Tests | 2 | 2025 | 5 | 0.410 |
Why?
|
| Primary Health Care | 1 | 2018 | 722 | 0.370 |
Why?
|
| Otitis Media | 2 | 2022 | 12 | 0.360 |
Why?
|
| Middle Aged | 8 | 2026 | 18274 | 0.350 |
Why?
|
| Male | 12 | 2026 | 31070 | 0.340 |
Why?
|
| Mastoid | 2 | 2020 | 7 | 0.330 |
Why?
|
| Female | 11 | 2026 | 34099 | 0.310 |
Why?
|
| Aged | 6 | 2026 | 14956 | 0.300 |
Why?
|
| Retrospective Studies | 6 | 2023 | 6876 | 0.270 |
Why?
|
| Cognition | 2 | 2022 | 502 | 0.270 |
Why?
|
| Head Impulse Test | 1 | 2025 | 2 | 0.240 |
Why?
|
| Rotation | 1 | 2025 | 25 | 0.230 |
Why?
|
| Acoustic Stimulation | 3 | 2025 | 50 | 0.230 |
Why?
|
| Pleasure | 2 | 2015 | 13 | 0.230 |
Why?
|
| Case-Control Studies | 2 | 2025 | 1155 | 0.220 |
Why?
|
| Healthy Volunteers | 1 | 2025 | 72 | 0.220 |
Why?
|
| Semicircular Canals | 2 | 2022 | 5 | 0.220 |
Why?
|
| Otolaryngologists | 2 | 2021 | 2 | 0.210 |
Why?
|
| Endoscopy | 2 | 2021 | 95 | 0.200 |
Why?
|
| Cadaver | 2 | 2020 | 128 | 0.200 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2023 | 4 | 0.200 |
Why?
|
| Vestibule, Labyrinth | 1 | 2022 | 9 | 0.190 |
Why?
|
| Tympanic Membrane | 2 | 2021 | 4 | 0.190 |
Why?
|
| Vasculitis | 1 | 2023 | 50 | 0.190 |
Why?
|
| Rheumatic Diseases | 1 | 2023 | 42 | 0.190 |
Why?
|
| Diagnosis, Differential | 1 | 2025 | 995 | 0.190 |
Why?
|
| Executive Function | 1 | 2022 | 66 | 0.180 |
Why?
|
| Phenotype | 1 | 2026 | 1242 | 0.180 |
Why?
|
| Cholesteatoma, Middle Ear | 1 | 2021 | 6 | 0.180 |
Why?
|
| Osteomyelitis | 1 | 2022 | 24 | 0.180 |
Why?
|
| Eustachian Tube | 1 | 2021 | 6 | 0.170 |
Why?
|
| Nasopharynx | 1 | 2021 | 21 | 0.170 |
Why?
|
| Medical History Taking | 1 | 2021 | 67 | 0.170 |
Why?
|
| Salivary Glands | 1 | 2021 | 45 | 0.170 |
Why?
|
| Autoimmune Diseases | 1 | 2023 | 242 | 0.170 |
Why?
|
| Neurotology | 1 | 2020 | 4 | 0.170 |
Why?
|
| Quality of Life | 3 | 2023 | 1270 | 0.160 |
Why?
|
| Vaccines | 1 | 2022 | 98 | 0.160 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 410 | 0.160 |
Why?
|
| Health Services Accessibility | 1 | 2025 | 594 | 0.160 |
Why?
|
| Young Adult | 2 | 2025 | 4817 | 0.140 |
Why?
|
| Occupational Exposure | 1 | 2020 | 319 | 0.130 |
Why?
|
| Comorbidity | 1 | 2020 | 1126 | 0.130 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1048 | 0.110 |
Why?
|
| United States | 2 | 2025 | 8121 | 0.110 |
Why?
|
| Adolescent | 1 | 2025 | 6358 | 0.110 |
Why?
|
| Animals | 3 | 2022 | 21570 | 0.100 |
Why?
|
| Operating Rooms | 2 | 2020 | 60 | 0.080 |
Why?
|
| Mice | 1 | 2019 | 11243 | 0.060 |
Why?
|
| Hearing | 1 | 2023 | 28 | 0.050 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2023 | 1 | 0.050 |
Why?
|
| Otolithic Membrane | 1 | 2022 | 2 | 0.050 |
Why?
|
| Pharynx | 1 | 2023 | 25 | 0.050 |
Why?
|
| Dilatation | 1 | 2022 | 34 | 0.050 |
Why?
|
| Cochlea | 1 | 2022 | 14 | 0.050 |
Why?
|
| Skull Base | 1 | 2022 | 12 | 0.050 |
Why?
|
| Debridement | 1 | 2022 | 33 | 0.050 |
Why?
|
| Otoscopy | 1 | 2021 | 1 | 0.050 |
Why?
|
| Ear Canal | 1 | 2021 | 4 | 0.040 |
Why?
|
| Ear, Middle | 1 | 2021 | 8 | 0.040 |
Why?
|
| Audiometry | 1 | 2021 | 13 | 0.040 |
Why?
|
| Auditory Threshold | 1 | 2021 | 26 | 0.040 |
Why?
|
| Fluorescein | 1 | 2020 | 13 | 0.040 |
Why?
|
| Temporal Bone | 1 | 2020 | 19 | 0.040 |
Why?
|
| Simulation Training | 1 | 2021 | 61 | 0.040 |
Why?
|
| Microscopy | 1 | 2020 | 100 | 0.040 |
Why?
|
| Vaccination | 1 | 2022 | 376 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 182 | 0.040 |
Why?
|
| Occupational Health | 1 | 2020 | 197 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2021 | 1010 | 0.030 |
Why?
|
| Surgeons | 1 | 2020 | 185 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 739 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2021 | 728 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 818 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 1188 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 1671 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 2101 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 2779 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2023 | 5819 | 0.020 |
Why?
|